Ferronova

About Ferronova

Ferronova develops surgical oncology tracers and imaging agents to improve cancer treatment guidance and staging. Its FerroTrace nanoparticle platform targets lymph nodes to enable precise intraoperative visualization and accurate identification of high-risk nodes, supporting decision-making in upper gastrointestinal cancers. The company focuses on lymphatic mapping, MRI visibility, and radiation-free tools for cancer surgery, with clinical trials in Australia involving gastric and esophageal cancer settings.